Published in J Drug Issues on January 01, 2011
Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) (2012) 1.15
Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics. Pain (2015) 0.91
Patterns of prescription opioid abuse and comorbidity in an aging treatment population. J Subst Abuse Treat (2011) 0.90
Under treatment of pain: a prescription for opioid misuse among the elderly? Pain Med (2013) 0.84
Health and social problems associated with prescription opioid misuse among a diverse sample of substance-using MSM. Subst Use Misuse (2013) 0.83
The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability. J Pain Res (2015) 0.80
Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse. J Addict Med (2015) 0.79
Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm (2015) 0.77
Diversion of benzodiazepines through healthcare sources. J Psychoactive Drugs (2013) 0.76
Spatial analysis of drug poisoning deaths in the American West, particularly Utah. Int J Drug Policy (2016) 0.75
Prescription Drug Diversion: Predictors of Illicit Acquisition and Redistribution in Three U.S. Metropolitan Areas. AIMS Public Health (2015) 0.75
Correlates of prescription drug market involvement among young adults. Drug Alcohol Depend (2014) 0.75
Doctor Shopping Behavior and the Diversion of Prescription Opioids. Subst Abuse (2017) 0.75
Use of the Internet to Obtain Drugs without a Prescription Among Treatment-involved Adolescents and Young Adults. J Child Adolesc Subst Abuse (2016) 0.75
Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003) (2016) 0.75
Heroin use onset among nonmedical prescription opioid users in the club scene. Drug Alcohol Depend (2017) 0.75
College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend (2003) 6.80
Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med (2010) 4.73
Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician (2010) 3.18
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf (2007) 2.65
The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse (2004) 2.53
Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. Can Fam Physician (2009) 1.77
Prescription drug misuse. Aust Fam Physician (2010) 1.58
Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse (2001) 1.42
Prescription drugs purchased through the internet: who are the end users? Drug Alcohol Depend (2010) 1.28
Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm (2009) 1.28
Prescription drug diversion control and medical practice. JAMA (1992) 1.26
Comparability of epidemiological information between self- and interviewer-administered questionnaires. J Clin Epidemiol (2002) 1.17
Prescription-type drug misuse and workplace access among nurses. J Addict Dis (1999) 1.16
A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction (2009) 1.15
Monitoring risk: post marketing surveillance and signal detection. Drug Alcohol Depend (2009) 1.15
Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008. J Pain Palliat Care Pharmacother (2010) 1.12
Prescription Drug Abuse & Diversion: Role of the Pain Clinic. J Drug Issues (2010) 1.07
An overview of prescription drug misuse and abuse: defining the problem and seeking solutions. J Law Med Ethics (1994) 1.06
Hospital drug diversion: the verdict is in. Health Matrix (1987) 1.05
Substance abuse among physicians. CMAJ (2000) 1.05
Use of prescription forgeries in a drug abuse surveillance network. Eur J Clin Pharmacol (1989) 1.03
Risk management of drug products and the U.S. Food and Drug Administration: evolution and context. Drug Alcohol Depend (2009) 1.02
Applying an extended theoretical framework for data collection mode to health services research. BMC Health Serv Res (2010) 0.93
Signal detection in post-marketing surveillance for controlled substances. Drug Alcohol Depend (2009) 0.92
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report. Drug Alcohol Depend (2009) 0.92
Empirical view of opioid dependence. J Manag Care Pharm (2010) 0.91
Workplace access, negative proscriptions, job strain, and substance use in registered nurses. Nurs Res (2000) 0.89
FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse. J Opioid Manag (2009) 0.87
Who is addicted to, and dying from, prescription opioids? J Am Geriatr Soc (2010) 0.85
Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals. Pharmacoepidemiol Drug Saf (2010) 0.85
Regulatory challenges for new formulations of controlled substances in today's environment. Drug Alcohol Depend (2006) 0.80
Effects of positive affect on risk perceptions in adolescence and young adulthood. J Adolesc (2010) 0.78
Abuse deterrent formulations and the Controlled Substances Act (CSA). Drug Alcohol Depend (2006) 0.78
Investigation of temporal changes of abuse and misuse of prescription opioids. J Addict Dis (2010) 0.77
Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med (2015) 4.50
Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain (2005) 4.27
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med (2007) 3.56
Effect of abuse-deterrent formulation of OxyContin. N Engl J Med (2012) 2.67
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf (2007) 2.65
Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med (2009) 2.13
Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain (2008) 1.75
HIV/AIDS among probationers: an assessment of risk and results from a brief intervention. J Psychoactive Drugs (2004) 1.73
The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med (2007) 1.70
Barriers to health and social services for street-based sex workers. J Health Care Poor Underserved (2005) 1.62
Foundations of opioid risk management. Clin J Pain (2007) 1.60
The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse (2006) 1.47
Migration, neighborhoods, and networks: approaches to understanding how urban environmental conditions affect syndemic adverse health outcomes among gay, bisexual and other men who have sex with men. AIDS Behav (2011) 1.47
The "black box" of prescription drug diversion. J Addict Dis (2009) 1.42
Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse (2007) 1.30
Prescription drugs purchased through the internet: who are the end users? Drug Alcohol Depend (2010) 1.28
Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance-using MSM. AIDS Educ Prev (2012) 1.28
Use and misuse of buprenorphine in the management of opioid addiction. J Opioid Manag (2008) 1.25
Evaluating component effects of a prison-based treatment continuum. J Subst Abuse Treat (2002) 1.25
Prescription drug abuse among ecstasy users in Miami. J Addict Dis (2005) 1.20
Source of drugs for prescription opioid analgesic abusers: a role for the Internet? Pain Med (2008) 1.16
Partner relationships and HIV risk behaviors among women offenders. J Psychoactive Drugs (2008) 1.16
HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida. AIDS Behav (2006) 1.15
Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15
Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) (2012) 1.15
Prescription opioid abuse among drug-involved street-based sex workers. J Opioid Manag (2007) 1.13
A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage (2006) 1.13
Assessment of the abuse of tapentadol immediate release: the first 24 months. J Opioid Manag (2012) 1.11
Changing patterns of cocaine use and hiv risks in the south of Brazil. J Psychoactive Drugs (2006) 1.11
Driven by prescription drug abuse, heroin use increases among suburban and rural whites. JAMA (2014) 1.08
Diversion and abuse of methadone prescribed for pain management. JAMA (2005) 1.07
Prescription Drug Abuse & Diversion: Role of the Pain Clinic. J Drug Issues (2010) 1.07
HIV risk among female sex workers in Miami: the impact of violent victimization and untreated mental illness. AIDS Care (2011) 1.06
Treatment during transition from prison to community and subsequent illicit drug use. J Subst Abuse Treat (2005) 1.06
Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health (2013) 1.06
HIV risk among substance-using men who have sex with men and women (MSMW): findings from South Florida. AIDS Behav (2014) 1.06
Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA. AIDS Care (2013) 1.05
Relationship influence and health risk behavior among re-entering women offenders. Womens Health Issues (2011) 1.05
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf (2009) 1.04
Alternate routes of administration and risk for HIV among prescription opioid abusers. J Addict Dis (2011) 1.03
An effective HIV risk-reduction protocol for drug-using female sex workers. J Prev Interv Community (2010) 1.03
The Diversion of Ultram, Ultracet, and generic tramadol HCL. J Addict Dis (2006) 1.02
Risk and protective factors associated with gay neighborhood residence. Am J Mens Health (2012) 1.01
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01
Integrating an HIV/HCV brief intervention in prisoner reentry: results of a multisite prospective study. J Psychoactive Drugs (2008) 1.00
Prevalence of narcotic analgesic abuse among students: individual or polydrug abuse? Arch Pediatr Adolesc Med (2004) 1.00
Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Saf (2014) 0.97
Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States. N Engl J Med (2015) 0.96
Substance use and sexual risk mediated by social support among Black men. J Community Health (2013) 0.94
Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N Engl J Med (2005) 0.93
Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. J Exp Criminol (2009) 0.93
Tri-city study of Ecstasy use problems: a latent class analysis. Drug Alcohol Depend (2008) 0.92
An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend (2003) 0.92
Postmarketing surveillance for drug abuse. Drug Alcohol Depend (2003) 0.92
Crowdsourcing black market prices for prescription opioids. J Med Internet Res (2013) 0.91
Benzodiazepine dependence among multidrug users in the club scene. Drug Alcohol Depend (2011) 0.91
Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend (2007) 0.91
Interview as intervention: the case of young adult multidrug users in the club scene. J Subst Abuse Treat (2012) 0.90
Patterns of prescription opioid abuse and comorbidity in an aging treatment population. J Subst Abuse Treat (2011) 0.90
The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations. AIDS Behav (2015) 0.88
Correlates of heterosexual anal intercourse among substance-using club-goers. Arch Sex Behav (2010) 0.88